Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azadeh Eshraghi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of Preventive Medicine|August 10, 2013
Association of polymorphism of ser311cys paraoxonase-2 gene with type 2 diabetes mellitus in iranSasan Andalib, Golnaz Vaseghi, Azadeh Motavallian, et al.
Current Clinical Pharmacology|July 6, 2017
The Role of N-Acetylcysteine in Platelet Aggregation and Reperfusion Injury in Recent YearsMohammadreza Nikbakht, Farhad Ahmadi, Golnaz Vaseghi, et al.
Reviews on Recent Clinical Trials|March 10, 2018
Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical TrialMinoo Batooei, Ahmad Tahamoli-Roudsari, Zahra Basiri, et al.
American Journal of Therapeutics|November 13, 2018
Preventive Effect of L-Carnitine on Scar Formation During Acute Pyelonephritis: A Randomized Placebo-Controlled TrialAlaleh Gheissari, Nahid Aslani, Azadeh Eshraghi, et al.
Reviews on Recent Clinical Trials|September 17, 2016
QT Dispersion and Age; Independent Predictors of Restenosis after Percutaneous Coronary InterventionNaser Aslanabadi, Sirous Vosooghi Moghadam, Babak Kazemi, et al.
American Journal of Therapeutics|August 21, 2015
Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial InfarctionAzadeh Eshraghi, Azita Hajhossein Talasaz, Jamshid Salamzadeh, et al.
Reviews on Recent Clinical Trials|January 8, 2025
Empagliflozin Ameliorates the Oxidative Stress Profile in Type 2 Diabetic Patients with Heart Failure and Reduced Ejection Fraction: Results of a Randomized, Double-blind, Placebo-controlled StudyAzadeh Eshraghi, Somayeh Khalesi, Kiumarth Amini, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 12, 2018
Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary CenterYounes Nozari, Azadeh Eshraghi, Azita Hajhossein Talasaz, et al.
Advanced Biomedical Research|September 25, 2014
Study of the possible medical and medication explanatory factors of angiographic outcomes in patients with acute ST elevation myocardial infarction undergoing primary percutaneous interventionAzadeh Eshraghi, Azita Hajhossein Talasaz, Jamshid Salamzadeh, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Preventive Medicine|August 10, 2013
Association of polymorphism of ser311cys paraoxonase-2 gene with type 2 diabetes mellitus in iranSasan Andalib, Golnaz Vaseghi, Azadeh Motavallian, et al.
Current Clinical Pharmacology|July 6, 2017
The Role of N-Acetylcysteine in Platelet Aggregation and Reperfusion Injury in Recent YearsMohammadreza Nikbakht, Farhad Ahmadi, Golnaz Vaseghi, et al.
Reviews on Recent Clinical Trials|March 10, 2018
Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical TrialMinoo Batooei, Ahmad Tahamoli-Roudsari, Zahra Basiri, et al.
American Journal of Therapeutics|November 13, 2018
Preventive Effect of L-Carnitine on Scar Formation During Acute Pyelonephritis: A Randomized Placebo-Controlled TrialAlaleh Gheissari, Nahid Aslani, Azadeh Eshraghi, et al.
Reviews on Recent Clinical Trials|September 17, 2016
QT Dispersion and Age; Independent Predictors of Restenosis after Percutaneous Coronary InterventionNaser Aslanabadi, Sirous Vosooghi Moghadam, Babak Kazemi, et al.
American Journal of Therapeutics|August 21, 2015
Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial InfarctionAzadeh Eshraghi, Azita Hajhossein Talasaz, Jamshid Salamzadeh, et al.
Reviews on Recent Clinical Trials|January 8, 2025
Empagliflozin Ameliorates the Oxidative Stress Profile in Type 2 Diabetic Patients with Heart Failure and Reduced Ejection Fraction: Results of a Randomized, Double-blind, Placebo-controlled StudyAzadeh Eshraghi, Somayeh Khalesi, Kiumarth Amini, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 12, 2018
Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary CenterYounes Nozari, Azadeh Eshraghi, Azita Hajhossein Talasaz, et al.
Advanced Biomedical Research|September 25, 2014
Study of the possible medical and medication explanatory factors of angiographic outcomes in patients with acute ST elevation myocardial infarction undergoing primary percutaneous interventionAzadeh Eshraghi, Azita Hajhossein Talasaz, Jamshid Salamzadeh, et al.
Pageof 4